Samsung Biologics to present at the 2026 J.P. Morgan Healthcare Conference
Samsung Biologics will participate in the 44th J.P. Morgan Healthcare Conference in San Francisco from January 12–15, 2026.
During the main track presentation on January 13, John Rim, CEO and President of Samsung Biologics, will deliver a business update highlighting the progress made in 2025 and the strategies for the year ahead. The presentation will focus on the company’s role as a pure-play CDMO under its ExellenS™ manufacturing framework, alongside continued expansion across manufacturing capacity, business portfolio, and global operations.
Throughout the conference week, Samsung Biologics will also meet with investors and potential clients at the Biotech Showcase to discuss areas for collaboration across biopharmaceutical development and manufacturing.
Samsung Biologics will participate in the 44th J.P. Morgan Healthcare Conference in San Francisco from January 12–15, 2026.
During the main track presentation on January 13, John Rim, CEO and President of Samsung Biologics, will deliver a business update highlighting the progress made in 2025 and the strategies for the year ahead. The presentation will focus on the company’s role as a pure-play CDMO under its ExellenS™ manufacturing framework, alongside continued expansion across manufacturing capacity, business portfolio, and global operations.
Throughout the conference week, Samsung Biologics will also meet with investors and potential clients at the Biotech Showcase to discuss areas for collaboration across biopharmaceutical development and manufacturing.
Share article
Related Content